Matthew ADAMOWICZ

Person

  • Bridgewater, NJ, US

Patents Grantslast 30 patents

  • Information Patent Grant

    Gene therapy for retinitis pigmentosa

    • Patent number 11,103,598
    • Issue date Aug 31, 2021
    • Genzyme Corporation
    • Catherine O'Riordan
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Gene therapy for retinitis pigmentosa

    • Patent number 10,383,953
    • Issue date Aug 20, 2019
    • Genzyme Corporation
    • Catherine O'Riordan
    • C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

  • Information Patent Application

    Treatment of Dry Age-Related Macular Degeneration

    • Publication number 20240401082
    • Publication date Dec 5, 2024
    • Genzyme Corporation
    • Matthew Adamowicz
    • C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
  • Information Patent Application

    GENE THERAPY FOR RETINITIS PIGMENTOSA

    • Publication number 20220054657
    • Publication date Feb 24, 2022
    • Genzyme Corporation
    • Catherine O'RIORDAN
    • C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
  • Information Patent Application

    GENE THERAPY FOR RETINITIS PIGMENTOSA

    • Publication number 20200046851
    • Publication date Feb 13, 2020
    • Genzyme Corporation
    • Catherine O'RIORDAN
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    GENE THERAPY FOR RETINITIS PIGMENTOSA

    • Publication number 20170173183
    • Publication date Jun 22, 2017
    • Genzyme Corporation
    • Catherine O'RIORDAN
    • C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...